REORGANIZATION AGREEMENT AMENDMENT NO. 3Reorganization Agreement • January 2nd, 2013 • Stalar 2, Inc. • Blank checks
This Amendment (“Amendment”) dated December 28, 2012 is to that Reorganization Agreement entered into made as of June 11, 2011, by and between LCTI Low Carbon Technologies International, Inc., a British Columbia corporation (“LCTI”) and Stalar 2, Inc., a Delaware corporation (the “Company”).
LETTER AGREEMENT Dated as of April 24, 2014Letter Agreement • April 29th, 2014 • Stalar 2, Inc. • Blank checks • New York
This letter agreement (“Agreement”) sets forth the terms and conditions of a transaction (the “Transaction”) whereby NanoMed Targeting Systems Inc., whose address is 4901 Richmond Square, Suite 103, Oklahoma City, OK 73118, or any of its successors, assigns, subsidiaries or affiliates (collectively referred to herein as the “Company”) will effect a reverse merger (the “Merger”) with and into Stalar 2, Inc., a Delaware corporation (the “Reporting Company”), an entity controlled by Dr. Steven Fox, whose address is c/o Dr. Steven Fox, 317 Madison Avenue, Suite 1520, New York, NY 10017. The Company and the Reporting Company may be referred to herein individually as a “Party” or collectively as the “Parties.”
REORGANIZATION AGREEMENTReorganization Agreement • June 14th, 2012 • Stalar 2, Inc. • Blank checks • Texas
This REORGANIZATION AGREEMENT dated as of June 11, 2012 (this “Agreement”) is by and between LCTI Low Carbon Technologies International, a British Columbia corporation (“LCTI”), and Stalar 2, Inc., a Delaware corporation (“Stalar”). LCTI and Stalar are collectively referred to herein as the “Parties”.
Reverse Merger Agreement Dated as of September 28, 2011Reverse Merger Agreement • September 30th, 2011 • Stalar 2, Inc. • Blank checks • New York
This letter confirms the agreement of Tennessee Materials, Inc., whose address is 1455 Bud Cleary Road, Stantonville, TN 38379, or any of its successors, assigns, subsidiaries or affiliates (collectively referred to herein as the “Company”) to effect a reverse merger (the “Merger”) with Stalar 2, Inc., a Delaware corporation (the “Reporting Company”), an entity controlled by Dr. Steven Fox, whose address is 317 Madison Avenue, Suite 1520, New York, NY 10017. The Merger shall be structured so that immediately following consummation of the Merger and any planned financing entered into in connection therewith, the previous shareholders of the Reporting Company, or their designees, shall continue to own shares of the Reporting Company equal to a total of five percent (5%) of the fully-diluted capital stock of the Reporting Company (calculated post-money, e.g. after any planned equity financing transaction involving the Reporting Company contemplated to occur prior to, simultaneously with,
